Worth Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200
Closed -$1.7K 137
2023
Q2
$1.7K Hold
200
﹤0.01% 395
2023
Q1
$1.83K Hold
200
﹤0.01% 419
2022
Q4
$2.28K Hold
200
﹤0.01% 404
2022
Q3
$3K Buy
+200
New +$4.29K ﹤0.01% 378

Other funds holding CDNA

Worth Asset Management's CDNA Position: Q3 2023 in Review

Worth Asset Management sold out of CareDx (CDNA) in Q3 2023, closing a stake of 200 shares — an estimated $1.7K sold.

Worth Asset Management first reported a position in CDNA in Q3 2022 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

  • Worth Asset Management reported no remaining CareDx position as of Q3 2023 after selling out during the quarter.
  • Worth Asset Management sold 200 CareDx shares in Q3 2023, an estimated $1.7K.
  • Worth Asset Management first reported a position in CareDx in Q3 2022 and held it in 4 quarters.
  • Worth Asset Management's CareDx position peaked at $3K in Q3 2022.
  • 150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.